Medicare Enrolled
Dr. Justin Harmon, DO
Surgery · Langhorne, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harmon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harmon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harmon
Dr. Justin Harmon is a surgery specialist in Langhorne, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Harmon performed 4,346 Medicare services across 3,588 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harmon received a total of $1,986 from 36 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harmon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in PA
$1,986 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,346
Medicare services
Top 1% in PA for surgery
3,588
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~229 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
892 | $8 | $60 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
835 | $3 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
739 | $68 | $195 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
381 | $94 | $275 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
204 | $65 | $150 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
168 | $194 | $545 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
162 | $122 | $360 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
102 | $20 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
82 | $100 | $285 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $134 | $390 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
76 | $101 | $489 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
58 | $75 | $195 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
53 | $41 | $80 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $28 | $75 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
43 | $63 | $195 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
42 | $263 | $710 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $135 | $415 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
36 | $46 | $170 |
| Simple change of bladder tube | 36 | $68 | $215 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
35 | $101 | $325 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
33 | $352 | $1,075 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
31 | $24 | $85 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
23 | $257 | $820 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
23 | $656 | $1,780 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $91 | $215 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
21 | $45 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $140 | $385 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $47 | $120 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
14 | $234 | $640 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
12 | $18 | $250 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
12 | $116 | $455 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
11 | $554 | $4,082 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.5% high complexity
25.7% medium
70.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,986
Total received (2018-2024)
Avg $284/year across 7 years
Top 40% in PA for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
84
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,968 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$645
2023
$347
2022
$234
2021
$206
2020
$155
2019
$184
2018
$214
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$172
Medtronic, Inc.
$122
PROGENICS PHARMACEUTICALS, INC.
$90
Astellas Pharma US Inc
$56
Calyxo, Inc.
$40
Boston Scientific Corporation
$35
Olympus America Inc.
$29
Smith+Nephew, Inc.
$27
Telix Pharmaceuticals
$20
Novartis Pharmaceuticals Corporation
$19
COLOPLAST CORP
$18
Alnylam Pharmaceuticals Inc.
$17
Top 3 companies account for 59.6% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$211
Astellas Pharma US Inc
$194
ABBVIE INC.
$172
Janssen Biotech, Inc.
$150
Boston Scientific Corporation
$130
PROCEPT BioRobotics Corporation
$125
PROGENICS PHARMACEUTICALS, INC.
$90
BOSTON SCIENTIFIC CORPORATION
$75
Myovant Sciences Inc.
$69
AXOGEN
$68
Axonics, Inc.
$67
Coloplast Corp
$55
Agiliti Surgical, Inc.
$53
Teleflex LLC
$50
Photocure Inc
$40
Calyxo, Inc.
$40
Laborie Medical Technologies Corp.
$39
Avadel Specialty Pharmaceuticals, LLC
$38
Olympus America Inc.
$29
Smith+Nephew, Inc.
$27
Intuitive Surgical, Inc.
$21
UROGEN PHARMA, INC.
$21
Telix Pharmaceuticals
$20
Novartis Pharmaceuticals Corporation
$19
Rochester Medical Corporation
$18
COLOPLAST CORP
$18
Alnylam Pharmaceuticals Inc.
$17
Allergan Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme LLC
$15
Medtronic USA, Inc.
$15
PFIZER INC.
$14
UROVANT SCIENCES INC
$14
Metuchen Pharmaceuticals
$14
Cook Medical LLC
$13
Allergan, Inc.
$13
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
AMS 700 · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AVANCE NERVE GRAFT · Axonics · BOTOX · Bulkamid · CVAC ASPIRATION SYSTEM · Cook Medical Urology · Cysview · Da Vinci Surgical System · Erleada · GEMTESA · GENERAL UTERINE TISSUE REMOVAL · GENERAL PELVIC ORGAN PROLAPSE · GRAFIX PL · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHOCLAST · LITHOVUE · LithoVue · MAGIC3 · MYCAMINE · MYRBETRIQ · Myrbetriq · Noctiva · ORGOVYX · OXLUMO · PLUVICTO · PYLARIFY · Porges Coloplast · SPEEDICATH · Sonablate · SpeediCath · Stendra · TOVIAZ · Titan · Tria Firm · UROLIFT · VESICARE · Veozah · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Surgerists within 10 mi
788
Per 100K population
122.0
County median income
$111,951
Nearest hospital
ST MARY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Harmon is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Harmon experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Harmon performed 892 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harmon receive payments from pharmaceutical companies?
Yes. Dr. Harmon received a total of $1,986 from 36 companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harmon's costs compare to other surgerists in Langhorne?
Dr. Harmon's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harmon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Langhorne
Browse surgerists in Langhorne ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in PA
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in PA
Which PA surgerists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology